Prevention of leukemia relapse by donor activating KIR2DS1.

The role of KIR genes and ligands in leukemia surveillance. Front Immunol (2013) 0.91

HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1. N Engl J Med (2012) 4.52

Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J Immunol (2002) 1.74

Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor. Haematologica (2008) 1.74

Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells. Blood (2012) 1.57

Asymmetric cell division within the human hematopoietic stem and progenitor cell compartment: identification of asymmetrically segregating proteins. Blood (2007) 1.34

Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells. BMC Res Notes (2010) 1.32

Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition. Blood (2010) 1.28

Conservation and variation in human and common chimpanzee CD94 and NKG2 genes. J Immunol (2002) 1.21

Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor. J Immunol (2007) 1.20

Induction of pluripotency in human cord blood unrestricted somatic stem cells. Exp Hematol (2010) 1.06

Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3. J Immunol (2005) 1.05

Rapid and highly efficient gene transfer into natural killer cells by nucleofection. J Immunol Methods (2003) 1.02

Neonatal NK-cell repertoires are functionally, but not structurally, biased toward recognition of self HLA class I. Blood (2011) 1.00

Molecular characterization of KIR3DL3. Immunogenetics (2006) 1.00

KIR expression shapes cytotoxic repertoires: a developmental program of survival. Trends Immunol (2002) 1.00

Epigenetic silencing of potentially functional KIR2DL5 alleles: Implications for the acquisition of KIR repertoires by NK cells. Eur J Immunol (2007) 0.98

MicroRNA-based promotion of human neuronal differentiation and subtype specification. PLoS One (2013) 0.95

Lineage-specific transition of histone signatures in the killer cell Ig-like receptor locus from hematopoietic progenitor to NK cells. J Immunol (2008) 0.92

IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion. Immunobiology (2010) 0.91

The role of KIR genes and ligands in leukemia surveillance. Front Immunol (2013) 0.91

Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands. Hum Immunol (2003) 0.88

Unrestricted somatic stem cells (USSC) from human umbilical cord blood display uncommitted epigenetic signatures of the major stem cell pluripotency genes. Stem Cell Res (2010) 0.88

Nucleolin regulates gene expression in CD34-positive hematopoietic cells. J Biol Chem (2007) 0.86

Histone methyltransferase enhancer of zeste homolog 2 regulates Schwann cell differentiation. Glia (2012) 0.85

Lack of association between KIR genes and acute lymphoblastic leukemia in children. Blood (2012) 0.84

The impact of HLA-C matching depends on the C1/C2 KIR ligand status in unrelated hematopoietic stem cell transplantation. Immunogenetics (2012) 0.83

Hepatocytes and IL-15: a favorable microenvironment for T cell survival and CD8+ T cell differentiation. J Immunol (2009) 0.83

Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes. Mol Cell Proteomics (2013) 0.83

T and NK cells of B cell NHL patients exert cytotoxicity against lymphoma cells following binding of bispecific tetravalent antibody CD19 × CD3 or CD19 × CD16. Cancer Immunol Immunother (2012) 0.82

Hepatocyte growth factor/c-MET axis-mediated tropism of cord blood-derived unrestricted somatic stem cells for neuronal injury. J Biol Chem (2008) 0.81

Psychologically adverse work conditions are associated with CD8+ T cell differentiation indicative of immunesenescence. Brain Behav Immun (2009) 0.80

Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis. Mult Scler (2011) 0.78

Delivery of DNA into natural killer cells for immunotherapy. Methods Mol Biol (2008) 0.78

Direct and quantitative analysis of chromatin accessibility by MIRECAL--a Micrococcus nuclease/real-time PCR chromatin accessibility assay with locus specificity. Anal Biochem (2006) 0.77

Expansion of NKG2A-LIR1- natural killer cells in HLA-matched, killer cell immunoglobulin-like receptors/HLA-ligand mismatched patients following hematopoietic cell transplantation. Biol Blood Marrow Transplant (2010) 0.76

Non-viral gene delivery into primary natural killer lymphocytes. FASEB J (2006) 0.75

Protocol for the clonal analysis of NK cell effector functions by multi-parameter flow cytometry. Methods Mol Biol (2012) 0.75